Analytical Data
-
Gene name
SCP
- Application
-
Alternative Names
SCP; BFRF3; Small capsomere-interacting protein
-
Species
Epstein-Barr virus
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P14348
-
Expression Region
31-176aa
-
Molecular Weight
30.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCP (Sperm-Coating Protein) recombinant proteins have garnered significant attention in the field of reproductive biology and biotechnology due to their critical role in sperm functionality and interaction with the female reproductive tract. These proteins, originally identified in various species, are integral for sperm motility, survival, and the fertilization process. The study of SCPs has expanded our understanding of sperm-egg interactions, enabling researchers to explore avenues for enhancing fertility treatments and contraceptive methods. Additionally, recombinant technology allows for the production of these proteins in a controlled environment, facilitating the investigation of their structure-function relationships and potential applications in diagnostics and therapeutics. By manipulating SCPs genetically, scientists aim to uncover their mechanisms of action and potential for improving reproductive outcomes in both humans and livestock. Given the rising interest in fertility issues globally, research on SCP recombinant proteins remains a pivotal area of exploration, with the potential to lead to novel solutions for infertility and advancements in reproductive health.
